Strides Pharma Science Q2 Results
- BSE: 532531
- NSE: STAR
- ISIN: INE939A01011
- Sector: Biotechnology & Drugs
BSE
1,419.15
-84.60 (-5.63%)
-84.60 (-5.63%)Volume17.28 K
Updated: Mon 25 Nov, 2024 | 15:47:42
NSE
1,417.45-86.80 (-5.77%)
-86.80 (-5.77%)Volume5.63 L
Updated: Mon 25 Nov, 2024 | 15:44:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,201.11 Cr.(10.45%)
- Operating Profit₹181.41 Cr.(10.18%)
- Profit After Tax₹93.23 Cr.(32.81%)
- Operating Margin15.10%(NA%)
Note: Comparison is on YoY basis
Quarterly - Strides Pharma Science Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,201.11 | 929.99 | -% | 999.43 | -% |
| Selling/ General/ Admin Expenses Total | 219.41 | 167.53 | -% | 199.93 | -% |
| Depreciation/ Amortization | 50.52 | 59.59 | -% | 60.10 | -% |
| Other Operating Expenses Total | 247.97 | 210.92 | -% | 228.28 | -% |
| Total Operating Expense | 1,019.70 | 828.97 | -% | 1,071.33 | -% |
| Operating Income | 181.41 | 101.02 | -% | -71.91 | -% |
| Net Income Before Taxes | 114.86 | 0.32 | -% | -156.90 | -% |
| Net Income | 93.23 | -7.11 | -% | -131.34 | -% |
| Diluted Normalized EPS | 10.46 | -0.36 | -% | -2.67 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST